| Rahul Dixit, MD | |
|
1 Trillium Way, Corbin, KY 40701-8426 | |
| (606) 521-8576 | |
| (606) 280-7570 |
| Full Name | Rahul Dixit |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 1 Trillium Way, Corbin, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225218167 | NPI | - | NPPES |
| 64282387 | Medicaid | KY | |
| 28238 | Other | KY | MEDICAL LICENSE |
| 000000187164 | Other | BLUE CROSS & BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 28238 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rahul Dixit, MD 1309 Smyrna Ln, Lexington, KY 40513-1754 Ph: (606) 521-8576 | Rahul Dixit, MD 1 Trillium Way, Corbin, KY 40701-8426 Ph: (606) 521-8576 |
News Archive
The advice given to reduce the risk of sudden infant death syndrome, SIDS, has worked well, but the potential to save more lives exists. In addition to sleeping on their backs, infants should sleep in their own beds for the first few months to reduce the risk of sudden infant death. A new doctoral thesis at Sahlgrenska Academy at University of Gothenburg has explored these issues.
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research today announced an investment of $415,000 towards the development of a radiolabelled insulin probe for the early detection of breast cancer.
A new report, based on data from the Framingham Heart Study (FHS), suggests that insulin resistance, a predictor of cardiovascular risk and the development of diabetes, may be modulated with even modest levels of physical activity.
Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage.
AmpliPhi BioSciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced that the Company will give a presentation today at the 21st Biennial Evergreen International Phage Meeting, taking place August 2-7 in Olympia, Wash.
› Verified 1 days ago
Vikki L Brock, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1202 W Nile St, Corbin, KY 40701 Phone: 606-261-5382 | |
Isaac Rafe Mills, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 270 Bacon Creek Rd, Corbin, KY 40701 Phone: 606-528-8822 |